An Updated Approach to Antiobesity Pharmacotherapy: Moving Beyond the 5% Weight Loss Goal
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Updated Approach to Antiobesity Pharmacotherapy: Moving Beyond the 5% Weight Loss Goal
Authors
Keywords
-
Journal
Journal of the Endocrine Society
Volume 7, Issue 3, Pages -
Publisher
The Endocrine Society
Online
2023-01-10
DOI
10.1210/jendso/bvac195
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association
- (2022) Joshua J. Joseph et al. CIRCULATION
- Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes
- (2022) Domenica M. Rubino et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Benefits of weight loss of 10% or more in patients with overweight or obesity: A review
- (2022) Abd A. Tahrani et al. Obesity
- Impact of Cotadutide drug on patients with type 2 diabetes mellitus: a systematic review and meta-analysis
- (2022) Mahmoud M. Ali et al. BMC Endocrine Disorders
- Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
- (2022) Takashi Kadowaki et al. Lancet Diabetes & Endocrinology
- Effect of an Interdisciplinary Weight Loss and Lifestyle Intervention on Obstructive Sleep Apnea Severity
- (2022) Almudena Carneiro-Barrera et al. JAMA Network Open
- International lack of equity in modern obesity therapy: the critical need for change in health policy
- (2022) Pia Roser et al. INTERNATIONAL JOURNAL OF OBESITY
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
- (2022) W. Timothy Garvey et al. NATURE MEDICINE
- Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity
- (2021) Thomas A. Wadden et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
- (2021) Melanie Davies et al. LANCET
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
- (2021) Domenica Rubino et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
- (2021) Lone B Enebo et al. LANCET
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
- (2021) Julio Rosenstock et al. LANCET
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
- (2021) Juan P. Frías et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial
- (2021) Juan P Frías et al. Lancet Diabetes & Endocrinology
- Introduction: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
- (2021) David C W Lau et al. LANCET
- Treatment of Obesity: Pharmacotherapy Trends of Office-Based Visits in the United States From 2011 to 2016
- (2021) Mechelle D. Claridy et al. MAYO CLINIC PROCEEDINGS
- Frequency and Consistency of Self‐Weighing to Promote Weight‐Loss Maintenance
- (2020) Andrea N. Brockmann et al. Obesity
- The Mitigating Effect of Phentermine and Topiramate on Weight Regain After Roux‐en‐Y Gastric Bypass Surgery
- (2020) Nawfal W. Istfan et al. Obesity
- Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
- (2020) Karine Clément et al. Lancet Diabetes & Endocrinology
- Safety and Effectiveness of Longer‐Term Phentermine Use: Clinical Outcomes from an Electronic Health Record Cohort
- (2019) Kristina H. Lewis et al. Obesity
- Physical Activity Energy Expenditure and Total Daily Energy Expenditure in Successful Weight Loss Maintainers
- (2019) Danielle M. Ostendorf et al. Obesity
- Routine clinical use of liraglutide 3 mg for the treatment of obesity: Outcomes in non‐surgical and bariatric surgery patients
- (2019) Mohamed Suliman et al. DIABETES OBESITY & METABOLISM
- Incorporating Weight Loss Medications into Hepatology Practice for Nonalcoholic Steatohepatitis
- (2019) Albert Do et al. HEPATOLOGY
- Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial
- (2019) Alexander Dimitri Miras et al. Lancet Diabetes & Endocrinology
- Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009‐2015
- (2019) David R. Saxon et al. Obesity
- Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity
- (2019) Zachary J. Ward et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes management before, during, and after bariatric and metabolic surgery
- (2018) Karim G. Kheniser et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Maintenance of Lost Weight and Long-Term Management of Obesity
- (2018) Kevin D. Hall et al. MEDICAL CLINICS OF NORTH AMERICA
- Efficacy of High-Dose Liraglutide as an Adjunct for Weight Loss in Patients with Prior Bariatric Surgery
- (2018) Peter Rye et al. OBESITY SURGERY
- The Effects of Exercise and Physical Activity on Weight Loss and Maintenance
- (2018) Damon L. Swift et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight
- (2018) Michael Rosenbaum et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Obesity and nonalcoholic fatty liver disease: current perspectives
- (2018) Raiya Sarwar et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity
- (2017) G Gomez et al. INTERNATIONAL JOURNAL OF OBESITY
- Current pharmacotherapy for obesity
- (2017) Gitanjali Srivastava et al. Nature Reviews Endocrinology
- Mechanisms, Pathophysiology, and Management of Obesity
- (2017) Steven B. Heymsfield et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Qualitative analysis of the role of self-weighing as a strategy of weight control for weight-loss maintainers in comparison with a normal, stable weight group
- (2016) Isabelle Carrard et al. APPETITE
- Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Body Fatness and Cancer — Viewpoint of the IARC Working Group
- (2016) Béatrice Lauby-Secretan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness and tolerability of liraglutide in patients with type 2 diabetes mellitus and obesity after bariatric surgery
- (2016) Juan J. Gorgojo-Martínez et al. Surgery for Obesity and Related Diseases
- Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
- (2016) Lancet Diabetes & Endocrinology
- The role of protein in weight loss and maintenance
- (2015) Heather J Leidy et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Biologic Responses to Weight Loss and Weight Regain: Report From an American Diabetes Association Research Symposium
- (2015) Rudolph L. Leibel et al. DIABETES
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- (2015) Caroline M. Apovian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Drugs Commonly Associated With Weight Change: A Systematic Review and Meta-analysis
- (2015) Juan Pablo Domecq et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomized clinical trial of a weight loss maintenance intervention in a primary care population
- (2015) Adam G. Tsai et al. Obesity
- Pharmacotherapy in Conjunction with a Diet and Exercise Program for the Treatment of Weight Recidivism or Weight Loss Plateau Post-bariatric Surgery: a Retrospective Review
- (2015) Jennifer Schwartz et al. OBESITY SURGERY
- Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study
- (2014) Bing Lu et al. ANNALS OF THE RHEUMATIC DISEASES
- Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss
- (2014) Sonja K. Billes et al. PHARMACOLOGICAL RESEARCH
- Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes
- (2013) John B. Buse et al. ANNALS OF INTERNAL MEDICINE
- Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults
- (2013) J van Can et al. INTERNATIONAL JOURNAL OF OBESITY
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis
- (2013) Gitanjali M. Singh et al. PLoS One
- Action and therapeutic potential of oxyntomodulin
- (2013) Alessandro Pocai Molecular Metabolism
- Smoking and overweight determine the likelihood of developing rheumatoid arthritis
- (2012) Maria J H de Hair et al. ANNALS OF THE RHEUMATIC DISEASES
- Zonisamide for Weight Reduction in Obese Adults
- (2012) Kishore M. Gadde et al. ARCHIVES OF INTERNAL MEDICINE
- Effects of Dietary Composition on Energy Expenditure During Weight-Loss Maintenance
- (2012) Cara B. Ebbeling et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
- (2011) Meredith C. Fidler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies
- (2011) The Emerging Risk Factors Collaboration LANCET
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Long-Term Persistence of Hormonal Adaptations to Weight Loss
- (2011) Priya Sumithran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity
- (2010) J. G. Kang et al. DIABETES OBESITY & METABOLISM
- The relationship between body mass index and hip osteoarthritis: A systematic review and meta-analysis
- (2010) Liying Jiang et al. JOINT BONE SPINE
- Antidepressants and Body Weight
- (2010) Alessandro Serretti et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of experimental weight perturbation on skeletal muscle work efficiency, fuel utilization, and biochemistry in human subjects
- (2009) Rochelle Goldsmith et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates
- (2009) Frank M. Sacks et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Exercise on 24-Month Weight Loss Maintenance in Overweight Women
- (2008) John M. Jakicic ARCHIVES OF INTERNAL MEDICINE
- Weight Regain Is Related to Decreases in Physical Activity during Weight Loss
- (2008) XUEWEN WANG et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now